Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Ibio Inc IBIO

iBio, Inc. is a preclinical stage biotechnology company that leverages artificial intelligence (AI) for the development of precision antibodies. The Company develops biopharmaceuticals using computational biology and 3D-modeling of subdominant and conformational epitopes, prospectively enabling the discovery of new antibody treatments for hard-to-target cancers and other diseases. Its StableHu... see more

NYSEAM:IBIO - Post Discussion

Ibio Inc > Getting noticed
View:
Post by Pandora on May 18, 2020 11:29am

Getting noticed

IBIO has come back to life after a number of down weeks. As development on all fronts slowly emerge on either a drug side or a manufacturing side it is betting noticed. Volumes are running high.
Comment by TRIPandROGAN on Jul 04, 2020 2:34pm
This post has been removed in accordance with Community Policy
Comment by Pandora on Jul 15, 2020 3:35pm
Two months later I guess I can just repeat what I said above! :-))
Comment by Pandora on Jul 20, 2020 12:00pm
July 20 - big jump this morning on no news. IBIO has one of the larger vaccine manufacturing facilities in the U.S. and a process called Fast Pharming which will allow them to manufacture a high number of doses regardless of whose vaccine it happens to be. In addition they are also working with the University of Texas on two vaccines of their own. Will it run once news comes out???
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities